Single Pot Processing: New oncology manufacturing line delivers higher yields and shorter cycle times.

“Dealing with highly potent solid oral dosage forms, we were looking for processing units that were safe, cGMP-compliant and protected the health and safety of our operators. We also wanted to maximize yields, prevent expensive product loss and reduce cycle times. These were the key factors that influenced our decision to purchase this technology and work with GEA.”